C4 Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: C4 Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: C4 Therapeutics Inc
Rating: 1.164486125
Author: Trendlyne DVM scores

Momentum Trap

about

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targe...

3.62 0.00 (0.00%)

29.98% Fall from 52W High

462.7K

XNAS Volume

XNAS 06 Aug, 2026 11:44 AM (EDT)

Board Meeting

The next board meeting for C4 Therapeutics Inc is on 07 Aug 2026 for the purpose of C4 Therapeutics Inc Second Quarter Earnings Results for 2026 See details

Low Financial Strength

11.1 / 100

Expensive Valuation

17.2 / 100

Technically Neutral

53.8 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 268%

6 analysts

C4 Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

C4 Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targe...

29.98% Fall from 52W High

SWOT Analysis

C4 Therapeutics Inc Live Price Chart

C4 Therapeutics Inc Live Price Chart